Found 2055 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: viral protein/immune system

Total Genus Sequence Length pdb Title
194 1124 7n5hA Cryo-em structure of broadly neutralizing antibody 2-36 in complex with prefusion sars-cov-2 spike glycoprotein
44 157 7mfgB Cryo-em structure of the vrc310 clinical trial, vaccine-elicited, human antibody 310-030-1d06 fab in complex with an h1 nc99 ha trimer
18 128 7n5hE Cryo-em structure of broadly neutralizing antibody 2-36 in complex with prefusion sars-cov-2 spike glycoprotein
47 322 7mfgA Cryo-em structure of the vrc310 clinical trial, vaccine-elicited, human antibody 310-030-1d06 fab in complex with an h1 nc99 ha trimer
15 120 7mfgE Cryo-em structure of the vrc310 clinical trial, vaccine-elicited, human antibody 310-030-1d06 fab in complex with an h1 nc99 ha trimer
12 108 7mfgF Cryo-em structure of the vrc310 clinical trial, vaccine-elicited, human antibody 310-030-1d06 fab in complex with an h1 nc99 ha trimer
18 107 7n5hF Cryo-em structure of broadly neutralizing antibody 2-36 in complex with prefusion sars-cov-2 spike glycoprotein
45 223 7s3nH Sars-cov-2 s stem helix peptide bound to fab22
3 10 7s3nA Sars-cov-2 s stem helix peptide bound to fab22
42 223 7s3mH Mers-cov s stem helix peptide bound to fab22
4 14 7s3mA Mers-cov s stem helix peptide bound to fab22
52 214 7s3nL Sars-cov-2 s stem helix peptide bound to fab22
48 217 7s3mL Mers-cov s stem helix peptide bound to fab22
208 1117 7s0cA Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody n-612-017
187 1130 7s0dA Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody n-612-014
30 223 7s0eH Structure of the sars-cov-2 s1 subunit in complex with antibody n-612-004
19 121 7rr0B Sars-cov-2 receptor binding domain bound to fab pdi 222
76 686 7s0eA Structure of the sars-cov-2 s1 subunit in complex with antibody n-612-004
28 214 7s0eL Structure of the sars-cov-2 s1 subunit in complex with antibody n-612-004
33 214 7s0cL Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody n-612-017
47 222 7s0bA Structure of the sars-cov-2 rbd in complex with neutralizing antibody n-612-056
32 194 7rr0A Sars-cov-2 receptor binding domain bound to fab pdi 222
36 225 7s0cH Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody n-612-017
31 214 7s0dL Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody n-612-014
38 199 7s0bE Structure of the sars-cov-2 rbd in complex with neutralizing antibody n-612-056
18 107 7rr0C Sars-cov-2 receptor binding domain bound to fab pdi 222
20 223 7s0dH Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody n-612-014
44 213 7s0bB Structure of the sars-cov-2 rbd in complex with neutralizing antibody n-612-056
31 209 7n64L Sars-cov-2 spike (2p) in complex with g32r7 fab (rbd and ntd local reconstruction)
47 216 7n4jL Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing human antibody wrair-2173.
34 277 7n62A Sars-cov-2 spike (2p) in complex with c12c9 fab (ntd local reconstruction)
45 199 7n4iC Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing human antibody wrair-2057.
14 117 7n9aA Potent neutralizing nanobodies resist convergent circulating variants of sars-cov-2 by targeting novel and conserved epitopes-covs rbd with nb21
30 277 7n64A Sars-cov-2 spike (2p) in complex with g32r7 fab (rbd and ntd local reconstruction)
44 223 7n62H Sars-cov-2 spike (2p) in complex with c12c9 fab (ntd local reconstruction)
30 230 7n64H Sars-cov-2 spike (2p) in complex with g32r7 fab (rbd and ntd local reconstruction)
37 221 7n4iH Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing human antibody wrair-2057.
44 202 7n4jA Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing human antibody wrair-2173.
203 1120 7n9eA Potent neutralizing nanobodies resist convergent circulating variants of sars-cov-2 by targeting novel and conserved epitopes-covs with nb34
25 195 7n9aE Potent neutralizing nanobodies resist convergent circulating variants of sars-cov-2 by targeting novel and conserved epitopes-covs rbd with nb21
11 126 7n9cD Potent neutralizing nanobodies resist convergent circulating variants of sars-cov-2 by targeting novel and conserved epitopes-covs with nb95
45 212 7n4iL Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing human antibody wrair-2057.
174 1121 7n9bA Potent neutralizing nanobodies resist convergent circulating variants of sars-cov-2 by targeting novel and conserved epitopes-covs with nb21
16 117 7n9bD Potent neutralizing nanobodies resist convergent circulating variants of sars-cov-2 by targeting novel and conserved epitopes-covs with nb21
17 125 7n9eD Potent neutralizing nanobodies resist convergent circulating variants of sars-cov-2 by targeting novel and conserved epitopes-covs with nb34
41 212 7n62L Sars-cov-2 spike (2p) in complex with c12c9 fab (ntd local reconstruction)
45 234 7n4jH Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing human antibody wrair-2173.
24 229 7mwwE Structure of hepatitis c virus envelope full-length glycoprotein 2 (ee2) from j6 genotype
17 233 7mwxC Structure of the core ectodomain of the hepatitis c virus envelope glycoprotein 2 with tamarin cd81
48 218 7mwwL Structure of hepatitis c virus envelope full-length glycoprotein 2 (ee2) from j6 genotype